Truist Financial Maintains Praxis Precision Medicines(PRAX.US) With Buy Rating

Futu NewsDec 21 02:31 · Ratings

Praxis Precision Medicines (PRAX) Gets a Buy From Truist Financial

TipRanksDec 21 01:39 · Ratings

Praxis Precision Medicines Announces Rare Pediatric Disease Designation Granted For Relutrigine In Dravet Syndrome; Praxis Plans To Initiate An All-DEE Trial (EMERALD), Inclusive Of Dravet Syndrome, In 1H2025

BenzingaDec 18 21:14

Express News | Praxis Precision Medicines Announces Rare Pediatric Disease Designation Granted for Relutrigine in Dravet Syndrome

BreakingsDec 18 21:00

9 Health Care Stocks With Whale Alerts In Today's Session

BenzingaDec 17 01:35

We're Not Very Worried About Praxis Precision Medicines' (NASDAQ:PRAX) Cash Burn Rate

Simply Wall StDec 13 19:50